These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1686544)

  • 1. [Left ventricular remodeling and ischemic heart diseases. Therapeutic possibilities].
    Cohen-Solal A; Himbert D; Paillole C; Chikli F; Dahan M; Steg PG; Juliard JM; Gourgon R
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():63-7. PubMed ID: 1686544
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Left ventricular remodeling after myocardial infarction].
    Anguenot T; Bassand JP; Bernard Y; Schiele F
    Arch Mal Coeur Vaiss; 1992 May; 85(5 Suppl):781-7. PubMed ID: 1530420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Ventricular "remodeling" after myocardial infarction].
    Cohen-Solal A; Himbert D; Guéret P; Gourgon R
    Arch Mal Coeur Vaiss; 1991 Jun; 84(6):847-53. PubMed ID: 1910327
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapeutic measures following acute myocardial infarct: differential use of PTCA, surgery and drugs].
    Noll G; Kaufmann U; Wenzel RR; Lüscher TF
    Schweiz Med Wochenschr; 1996 Feb; 126(5):164-76. PubMed ID: 8685687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Management of heart failure complicating acute myocardial infarction].
    Nakamura M; Yamaguchi T
    Nihon Rinsho; 1993 May; 51(5):1322-7. PubMed ID: 8331801
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiopathology of left ventricular remodeling after myocardial infarction].
    Bassand JP; Anguenot T
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():43-9. PubMed ID: 1838920
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ventricular remodeling and its prevention in the treatment of heart failure.
    Patten RD; Udelson JE; Konstam MA
    Curr Opin Cardiol; 1998 May; 13(3):162-7. PubMed ID: 9649938
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Integration of therapeutic options and the candidates for treatment: the ABC of the post-infarction period].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():132S-138S. PubMed ID: 9004813
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Action of converting enzyme inhibitors on myocardial ischemia and reperfusion injuries].
    Galinier M; Bounhoure JP
    Arch Mal Coeur Vaiss; 1993 Jul; 86 Spec No 4():99-104. PubMed ID: 8304819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of ACE-inhibitors and beta-blockers on left ventricular remodeling in chronic heart failure.
    Khattar RS
    Minerva Cardioangiol; 2003 Apr; 51(2):143-54. PubMed ID: 12783070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prevention of heart failure].
    Logeart D; Guiti C; Ennezat PV; Cohen-Solal A
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1333-41. PubMed ID: 9864601
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Left ventricular remodeling: pathophysiology and treatment.
    Sharpe N
    Heart Fail Monit; 2003; 4(2):55-61. PubMed ID: 14724719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Angiotensin converting enzyme inhibitors in ischemic heart disease].
    Takác M; Koval S; Takác V; Takác P
    Vnitr Lek; 1996 Apr; 42(4):290-6. PubMed ID: 8693718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immediate administration of mineralocorticoid receptor antagonist spironolactone prevents post-infarct left ventricular remodeling associated with suppression of a marker of myocardial collagen synthesis in patients with first anterior acute myocardial infarction.
    Hayashi M; Tsutamoto T; Wada A; Tsutsui T; Ishii C; Ohno K; Fujii M; Taniguchi A; Hamatani T; Nozato Y; Kataoka K; Morigami N; Ohnishi M; Kinoshita M; Horie M
    Circulation; 2003 May; 107(20):2559-65. PubMed ID: 12732605
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cardioprotection by angiotensin-converting enzyme (ACE) inhibitors.
    Juggi JS; Koenig-Berard E; Van Gilst WH
    Can J Cardiol; 1993 May; 9(4):336-52. PubMed ID: 8513428
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drugs for left ventricular remodeling in heart failure.
    Frigerio M; Roubina E
    Am J Cardiol; 2005 Dec; 96(12A):10L-18L. PubMed ID: 16399088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Angiotensin-converting enzyme inhibitors in patients with preserved left ventricular function: from EUROPA to PREAMI].
    Ferrari R; Papa K; Bernocchi P; Gimbatti OJ; Golcea SS; Bettini A; Ceconi C
    Ital Heart J; 2005 Nov; 6 Suppl 7():24S-32S. PubMed ID: 16485514
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Remodeling of the left ventricle after myocardial infarction].
    Droździak E; Piwowarska W
    Pol Merkur Lekarski; 1996 Oct; 1(4):219-22. PubMed ID: 9156927
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of the addition of a beta-blocker on left ventricular remodeling and prognosis in patients with dilated cardiomyopathy treated with angiotensin-converting enzyme inhibitor.
    Hamada M; Hara Y; Ohtsuka T; Suzuki J; Saeki H; Ogimoto A; Shigematsu Y
    J Cardiovasc Pharmacol; 2003 Jan; 41 Suppl 1():S5-10. PubMed ID: 12688389
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Rationale, characteristics and study design of PREAMI (Perindopril and Remodelling in the Elderly with Acute Myocardial Infraction)].
    Magrini G; Nicolosi GL; Chiariello M; Ferrari R; Remme P; Tavazzi L
    Ital Heart J; 2005 Nov; 6 Suppl 7():14S-23S. PubMed ID: 16485513
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.